Page last updated: 2024-10-30

metaproterenol and Placenta Diseases

metaproterenol has been researched along with Placenta Diseases in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janisch, H1
Leodolter, S1
Reinold, R1

Other Studies

1 other study available for metaproterenol and Placenta Diseases

ArticleYear
[Enhancing utero-placental blood flow with EPH-gestosis patients through long-term therapy with beta-sympathomimetica (author's transl)].
    Zeitschrift fur Geburtshilfe und Perinatologie, 1974, Volume: 178, Issue:3

    Topics: Adrenergic beta-Agonists; Female; Humans; Indium; Long-Term Care; Maternal-Fetal Exchange; Metaprote

1974
chemdatabank.com